Most recently, it's been discovered that conolidine and the above mentioned derivatives act to the atypical chemokine receptor 3 (ACKR3. Expressed in comparable areas as classical opioid receptors, it binds to some wide array of endogenous opioids. In contrast to most opioid receptors, this receptor acts as being a scavenger and does not activate a